Ultrazac D
Ultrazac D Products are primarily used for
Pain relief, Severe acute pain
About Ultrazac D Products
Uses of Ultrazac D Products
Domperidone+Paracetamol+Tramadol is used for pain relief and severe acute pain.
Ultrazac D Products side effects
Common
Side Effects of Ultrazac D are Nausea, Vomiting, Constipation, Dryness in mouth, Sleepiness, Weakness, Dizziness.
How Ultrazac D Products work
Domperidone + Paracetamol + Tramadol is a combination of three medicines: Domperidone, Paracetamol and Tramadol. Domperidone is a prokinetic which works on the region in the brain that controls vomiting. It increases the movement of the stomach and intestines, allowing food to move more easily through the stomach. Paracetamol is an analgesic (pain reliever) and an anti-pyretic (fever reducer) which works by blocking the release of certain chemical messengers that cause fever and pain. Tramadol is an opioid analgesic (pain reliever) which works by blocking the transmission of pain signals to the brain to lower pain perception.
Patient Concerns about Ultrazac D Products
Frequently asked questions about Ultrazac D Products
Frequently asked questions about Ultrazac D Products
Q. What are the instructions for the storage and disposal of Ultrazac D 10 mg/325 mg/37.5 mg Tablet?
Keep this medicine in the packet or the container it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.
Q. Can I discontinue the medicine when my pain is relieved?
Ultrazac D 10 mg/325 mg/37.5 mg Tablet is usually used for short term and can be discontinued when your pain is relieved. However, Ultrazac D 10 mg/325 mg/37.5 mg Tablet should be continued if advised by the doctor.
Q. Can the use of Ultrazac D 10 mg/325 mg/37.5 mg Tablet cause constipation?
Yes, the use of Ultrazac D 10 mg/325 mg/37.5 mg Tablet can cause constipation. Talk to your doctor about treating constipation, if it persists for a long time.
Q. Are there any specific contraindications associated with the use of Ultrazac D 10 mg/325 mg/37.5 mg Tablet?
Ultrazac D 10 mg/325 mg/37.5 mg Tablet should be avoided in patients with known allergy to any of the components or excipients of this medicine. Ultrazac D 10 mg/325 mg/37.5 mg Tablet can cause problems when used with the medicine that can cause sleepiness. It should also be avoided with MAO inhibitors (certain medicines that are used in the treatment of depression or Parkinson’s disease). Ultrazac D 10 mg/325 mg/37.5 mg Tablet should not be used in patients who are suffering from severe liver disease or epilepsy.
Q. Can the use of Ultrazac D 10 mg/325 mg/37.5 mg Tablet cause damage to the liver?
Ultrazac D 10 mg/325 mg/37.5 mg Tablet is usually safe when consumed in the recommended dose. However, an overdose of Ultrazac D 10 mg/325 mg/37.5 mg Tablet can damage your liver. Avoid drinking alcohol while taking this medicine, it may increase your risk of liver damage.
Q. Can the use of Ultrazac D 10 mg/325 mg/37.5 mg Tablet cause dry mouth?
Yes, the use of Ultrazac D 10 mg/325 mg/37.5 mg Tablet can cause dry mouth. If you experience dry mouth, drink plenty of water. Take regular sips during the day and keep some water by your bed at night. You may use lip balm if your lips are also dry.
Q. Can I take a higher than the recommended dose of Ultrazac D 10 mg/325 mg/37.5 mg Tablet?
No, taking a higher than the recommended dose of Ultrazac D 10 mg/325 mg/37.5 mg Tablet can lead to increased chances of side effects and liver damage. If the recommended dosage does not relieve your symptoms or you experience increased severity of pain, please consult your doctor for re-evaluation.
Products for Ultrazac D
Ultrazac D 10 mg/325 mg/37.5 mg Tablet
strip of 10 tablets
MRP
₹88.5
Not Available
Substitute brands for Ultrazac D
Trudol D
Best Biotech
1 Product
Duradol DP
Ridhima Biocare
1 Product
Fortipar-D
Winmark Pharmaceuticals Pvt Ltd
1 Product
Octram
Octavius Pharma Pvt Ltd
1 Product
Kedol Plus
Keen Healthcare Pvt Ltd
1 Product